Delivery Order SPE2DB24D2216-SPE2DB25FGPCG
- Not listed
- The Defense Logistics Agency awarded a $4,719.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PREVYMIS 480 mg tablets (7-count) on June 18, 2025, with an ultimate completion date of July 11, 2025. This non-set-aside competitive award reflects the pharmaceutical distributor's capability to meet federal medical procurement requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems,...
- The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for PREVYMIS 480 MG tablets (7-count packages) with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract action under AmerisourceBergen's broader relationship with the federal...
- The Defense Logistics Agency awarded a $4,719.34 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Prevymis 480 mg tablets (7-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 10, 2025, and represents a child order under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count packages) on September 8, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 29, 2025, represents a non-competitive award utilizing AmerisourceBergen's existing contract vehicle. The pharmaceutical distributor will perform this delivery from its corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $4,719.34 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Prevymis 480 mg tablets (quantity: 7 units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count units) with an ultimate completion date of August 25, 2025. This is a firm fixed price, non-set-aside contract that represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The $4,719.34 firm fixed-price delivery order is for the supply of PREVYMIS 480 MG TABLET 7S medication, with a period of performance through July 7, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of PREVYMIS 480 MG tablets in a quantity of 7 units, valued at $9,438.70. This is a firm fixed price delivery order issued on July 22, 2025, with an ultimate completion date of August 12, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, and the place of performance...
- The Defense Logistics Agency awarded a $18.88K delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of PREVYMIS 480 mg tablets (seven-count packaging). This is a competitively awarded, firm fixed-price contract with no set-aside designation, with performance to be completed by July 16, 2025, and fulfillment based in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $4.72K firm fixed-price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count units) with an ultimate completion date of August 26, 2025. This non-set-aside contract was competitively awarded on August 5, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPCGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for the supply of PREVYMIS 480 mg tablets (7-count packages) with a completion date of July 22, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on June 30, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract supports critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 6/30/25 |